SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001255294-15-000359
Filing Date
2015-06-29
Accepted
2015-06-29 09:55:29
Documents
1
Period of Report
2015-03-31
Effectiveness Date
2015-06-29

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm NT 10-K 17249
  Complete submission text file 0001255294-15-000359.txt   18350
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: NT 10-K | Act: 34 | File No.: 000-54767 | Film No.: 15956809
SIC: 2834 Pharmaceutical Preparations